Evaluation of a competitive binding assay for cortisol using horse transcortin.
A non-chromatographic competitive binding assay (CBA) using horse transcortin has been employed in the routine measurement of cortisol in plasma, urine and amniotic fluids. Comparing the values with those of a radioimmunoassay (RIA) or a fluorimetric method (FM) an excellent correlation between the three methods both in plasma and urine has been calculated in normal subjects and in patients with various endocrine disorders. In amniotic fluids, however, there were discrepancies between CBA and RIA. Whereas CBA showed no differences, RIA gave significantly higher values in amniotic fluids of female than of male fetuses. Elevated free plasma cortisol levels observed in patients with prostatic cancer after diethyl stilboestrol diphosphate therapy did not correlate with unconjugated urinary cortisol concentration as measured with CBA and FM. In newborns, a relatively high plasma level found 12 hours after birth was followed by a nadir on the 2nd and 3rd day of life and by an increase until levels of adults on the 5th day of life were reached.
D000653:Amniotic Fluid / Q000032:analysis; D000818:Animals; D001667:Binding, Competitive; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004700:Endocrine System Diseases / Q000378:metabolism; D005260:Female; D005312:Fetal Blood / Q000032:analysis; D006736:Horses; D006801:Humans; D006854:Hydrocortisone / Q000032:analysis* / Q000097:blood / Q000652:urine; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000378:metabolism; D011863:Radioimmunoassay / Q000379:methods; D012016:Reference Values; D014156:Transcortin
D004054:Diethylstilbestrol; D014156:Transcortin; D006854:Hydrocortisone